N-acetyltransferase 2 genotyping:: An accurate and feasible approach for simultaneous detection of the most common NAT2 alleles

被引：17

作者：

Brans, R

Laizane, D

Khan, A

Blömeke, B

机构：

[1] Univ Trier, Dept Ecotoxicol Toxicol, D-54290 Trier, Germany

[2] Rhein Westfal TH Aachen, Univ Hosp, Dept Dermatol & Allergol, Aachen, Germany

来源：

CLINICAL CHEMISTRY | 2004年 / 50卷 / 07期

关键词：

D O I：

10.1373/clinchem.2003.027748

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：1264 / 1266

页数：3

共 13 条

[1] Identification of N-acetyltransferase 2 genotypes by continuous monitoring of fluorogenic hybridization probes [J].

Blömeke, B ;

Sieben, S ;

Spötter, D ;

Landt, O ;

Merk, HF .

ANALYTICAL BIOCHEMISTRY, 1999, 275 (01) :93-97

[2] HUMAN ARYLAMINE N-ACETYLTRANSFERASE GENES - ISOLATION, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL EXPRESSION [J].

BLUM, M ;

GRANT, DM ;

MCBRIDE, W ;

HEIM, M ;

MEYER, UA .

DNA AND CELL BIOLOGY, 1990, 9 (03) :193-203

[3] NAT2*12A (803A->G) codes for rapid arylamine N-acetylation in humans [J].

Cascorbi, I ;

Brockmoller, J ;

Bauer, S ;

Reum, T ;

Roots, I .

PHARMACOGENETICS, 1996, 6 (03) :257-259

[4] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J].

CLARK, DWJ .

DRUGS, 1985, 29 (04) :342-375

[5] Arylamine N-acetyltransferase (NAT2) genotypes in Africans:: the identification of a new allele with nucleotide changes 481C>T and 590G>A [J].

Dandara, C ;

Masimirembwa, CM ;

Magimba, A ;

Kaaya, S ;

Sayi, J ;

Sommers, DK ;

Snyman, JR ;

Hasler, JA .

PHARMACOGENETICS, 2003, 13 (01) :55-58

[6] GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN [J].

EVANS, DAP ;

MANLEY, KA ;

MCKUSICK, VA .

BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) :485-491

[7] Pharmacogenetics in the laboratory and the clinic [J].

Goldstein, DB .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :553-556

[8]

Hein DW, 2000, DRUG METAB DISPOS, V28, P1425

[9] Molecular mechanisms of genetic polymorphisms of drug metabolism [J].

Meyer, UA ;

Zanger, UM .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :269-296

[10] Pharmacogenomics and reducing the frequency of adverse drug events [J].

O'Kane, DJ ;

Weinshilboum, RM ;

Moyer, TP .

PHARMACOGENOMICS, 2003, 4 (01) :1-4

← 1 2 →